Gearbox
Tartu, EE · 2 known investors
Find your way into Gearbox
Gearbox Biosciences develops Pop-Out-Plasmid (POP) technology, an E. coli platform that produces plasmid DNA and recombinant proteins without antibiotic selection markers or chemical inducers like IPTG, while decoupling growth from production. Its products serve biopharma partners in gene therapy, cell therapy, and vaccine manufacturing, and the technology is available for licensing.
Investors · 2
In the news
Frequently asked questions
- What does Gearbox do?
- Gearbox Biosciences develops Pop-Out-Plasmid (POP) technology, an E. coli platform that produces plasmid DNA and recombinant proteins without antibiotic selection markers or chemical inducers like IPTG, while decoupling growth from production. Its products serve biopharma partners in gene therapy, cell therapy, and vaccine manufacturing, and the technology is available for licensing.
- Who are Gearbox's investors?
- Gearbox's investors include Specialist VC, Placeholder.
- Where is Gearbox headquartered?
- Gearbox is headquartered in Tartu, EE.